0001209191-21-070453.txt : 20211217 0001209191-21-070453.hdr.sgml : 20211217 20211217195902 ACCESSION NUMBER: 0001209191-21-070453 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211217 FILED AS OF DATE: 20211217 DATE AS OF CHANGE: 20211217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lager Joanne Jenkins CENTRAL INDEX KEY: 0001816215 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39401 FILM NUMBER: 211503341 MAIL ADDRESS: STREET 1: C/O ITEOS THERAPEUTICS, INC. STREET 2: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: iTeos Therapeutics, Inc. CENTRAL INDEX KEY: 0001808865 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 857-204-4583 MAIL ADDRESS: STREET 1: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-12-17 0 0001808865 iTeos Therapeutics, Inc. ITOS 0001816215 Lager Joanne Jenkins 139 MAIN STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Medical Officer Common Stock 2021-12-17 4 M 0 7000 4.30 A 7000 D Common Stock 2021-12-17 4 S 0 7000 41.00 D 0 D Stock Option (right to buy) 4.30 2021-12-17 4 M 0 7000 0.00 D 2025-06-11 Common Stock 7000 196438 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 23, 2021. One-fourth of the shares subject to the stock option vested on April 1, 2020. Thereafter, 1/48 of the shares subject to the stock option vest on a monthly basis, subject to the reporting person's continuous service relationship with the Issuer through each applicable vesting date. /s/ Adi Osovsky, as Attorney-in-Fact 2021-12-17